Your browser doesn't support javascript.
loading
Correction: TERT promoter mutation in adult granulosa cell tumor of the ovary.
Pilsworth, Jessica A; Cochrane, Dawn R; Xia, Zhouchunyang; Aubert, Geraldine; Färkkilä, Anniina E M; Horlings, Hugo M; Yanagida, Satoshi; Yang, Winnie; Lim, Jamie L P; Wang, Yi Kan; Bashashati, Ali; Keul, Jacqueline; Wong, Adele; Norris, Kevin; Brucker, Sara Y; Taran, Florin-Andrei; Krämer, Bernhard; Staebler, Annette; van Meurs, Hannah; Oliva, Esther; Shah, Sohrab P; Kommoss, Stefan; Kommoss, Friedrich; Gilks, C Blake; Baird, Duncan M; Huntsman, David G.
Afiliación
  • Pilsworth JA; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
  • Cochrane DR; Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Xia Z; Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Aubert G; Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Färkkilä AEM; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Horlings HM; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Yanagida S; Children's Hospital and Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Yang W; Department of Radiation Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Lim JLP; Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Wang YK; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Bashashati A; Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan.
  • Keul J; Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Wong A; Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Norris K; Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Brucker SY; Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Taran FA; Department of Women's Health, Tübingen University Hospital, Tübingen, Germany.
  • Krämer B; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
  • Staebler A; Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK.
  • van Meurs H; Department of Women's Health, Tübingen University Hospital, Tübingen, Germany.
  • Oliva E; Department of Women's Health, Tübingen University Hospital, Tübingen, Germany.
  • Shah SP; Department of Women's Health, Tübingen University Hospital, Tübingen, Germany.
  • Kommoss S; Tübingen University Hospital, Institute of Pathology, Tübingen, Germany.
  • Kommoss F; Department of Gynecology, Center for Gynecologic Oncology Amsterdam, Academic Medical Center, 1100 DD, Amsterdam, The Netherlands.
  • Gilks CB; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
  • Baird DM; Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Huntsman DG; Department of Computer Science, University of British Columbia, Vancouver, BC, Canada.
Mod Pathol ; 32(4): 593, 2019 04.
Article en En | MEDLINE | ID: mdl-29968850
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mod Pathol Asunto de la revista: PATOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mod Pathol Asunto de la revista: PATOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos